Related Experiment Videos
Cognitive aging and Alzheimer's disease.
1Neurology Department, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. rik.vandenberghe@uz.kuleuven.ac.be
Postgraduate Medical Journal
|June 7, 2005
Summary
Distinguishing cognitive aging from Alzheimer's disease is possible using clinical tests and brain imaging. Advances in cognitive systems and molecular research are crucial for addressing the growing Alzheimer's challenge.
Area of Science:
- Neuroscience
- Gerontology
- Pathology
Background:
- Cognitive aging and Alzheimer's disease (AD) present distinct clinical and biological profiles.
- Neuroimaging and neuropsychological assessments are key diagnostic tools.
- Understanding the interplay between aging and neurodegeneration is critical.
Purpose of the Study:
- To highlight the methods for differentiating normal cognitive aging from Alzheimer's disease.
- To emphasize the importance of integrated research from cognitive systems to molecular levels.
- To underscore the need for advancements in both clinical and basic science to combat AD.
Main Methods:
- Clinical and neuropsychological testing.
- Structural and functional neuroimaging techniques.
- Investigation of cognitive brain systems and molecular mechanisms.
Main Results:
- Clinical and imaging approaches can effectively discriminate between cognitive aging and probable AD.
- Research at cognitive and molecular levels offers new insights into aging and neurodegeneration.
- Progress in both clinical and basic research is essential for managing AD.
Conclusions:
- Effective discrimination between cognitive aging and Alzheimer's disease is achievable.
- Integrated research approaches are vital for understanding neurodegenerative processes.
- Continued advancements are necessary to address the increasing prevalence of Alzheimer's disease.